Similar articles

• Adrenoleukodystrophy in the era of newborn screening.

  Eng L, Regelmann MO. Eng L, et al. Curr Opin Endocrinol Diabetes Obes. 2020 Feb;27(1):47-55. doi: 10.1097/MED.0000000000000515. Curr Opin Endocrinol Diabetes Obes. 2020. PMID: 31789721 Review.
• X-linked adrenoleukodystrophy: therapeutic approaches to distinct phenotypes.

  Mahmood A, Dubey P, Moser HW, Moser A. Mahmood A, et al. Pediatr Transplant. 2005 Dec;9 Suppl 7:55-62. doi: 10.1111/j.1399-3046.2005.00447.x. Pediatr Transplant. 2005. PMID: 16305618 Review.
• Magnetic resonance spectroscopy: a new guide for the therapy of adrenoleukodystrophy.

  Moser HW, Barker PB. Moser HW, et al. Neurology. 2005 Feb 8;64(3):406-7. doi: 10.1212/wnl.64.3.406. Neurology. 2005. PMID: 15699364 No abstract available.
• Childhood cerebral X-linked adrenoleukodystrophy more than 5 years after hematopoietic cell transplantation: the first case from Serbia and southeastern Europe.

  Potic A, Rovelli AM, Uziel G, Kozic D, Mladenovic J, Milic-Rasic V. Potic A, et al. J Child Neurol. 2010 Dec;25(12):1542-7. doi: 10.1177/0883073810375117. Epub 2010 Jul 22. J Child Neurol. 2010. PMID: 20656676
• [Neurological Peroxisomal Disorders with a Focus on Adrenoleukodystrophy].

  Shimozawa N. Shimozawa N. Brain Nerve. 2025 May;77(5):551-560. doi: 10.11477/mf.188160960770050551. Brain Nerve. 2025. PMID: 40350638 Review. Japanese.